Form 4 filed by ORBIMED ADVISORS LLC
ORBIMED ADVISORS LLC filed this Form 4 on Aspen Neuroscience, Inc. with 11 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-04 23:43:12 UTC.
- Accession
- 0000947871-26-000980
- Filer
- CIK 1055951
- Filed
- 2026-11-04
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: Aspen Neuroscience, Inc. (CIK 2124080)
- ORBIMED ADVISORS LLC director, 10% owner
- OrbiMed Capital GP VII LLC director, 10% owner
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-11-02 | C converted | +196,541 | 196,541 | I See footnotes | |
| Common Stock | 2026-11-02 | C converted | +642,745 | 839,286 | I See footnotes | |
| Common Stock | 2026-11-02 | C converted | +616,984 | 1,456,270 | I See footnotes | |
| Common Stock | 2026-11-02 | C converted | +625,743 | 2,082,013 | I See footnotes | |
| Common Stock | 2026-11-02 | C converted | +507,119 | 2,589,132 | I See footnotes | |
| Common Stock | 2026-11-02 | P bought | +1,000,000 | $15 | 3,589,132 | I See footnotes |
| Series Seed-2 Convertible Preferred Stock derivative | 2026-11-02 | C converted | -196,541 | $0 | 0 | I See footnotes |
| Series A-1 Convertible Preferred Stock derivative | 2026-11-02 | C converted | -642,745 | $0 | 0 | I See footnotes |
| Series A-2 Convertible Preferred Stock derivative | 2026-11-02 | C converted | -616,984 | $0 | 0 | I See footnotes |
| Series B Convertible Preferred Stock derivative | 2026-11-02 | C converted | -625,743 | $0 | 0 | I See footnotes |
| Series C Convertible Preferred Stock derivative | 2026-11-02 | C converted | -507,119 | $0 | 0 | I See footnotes |